Q BioMed Inc
Change company Symbol lookup
Select an option...
QBIO Q BioMed Inc
CIG Companhia Energetica de Minas Gerais CEMIG
VIVC Vivic Corp
DLMAF Dollarama Inc
RNDB Randolph Bancorp Inc
DQ Daqo New Energy Corp
KTHN Katahdin Bankshares Corp
SZC The Cushing? Renaissance Fund Common
SRV Cushing? MLP & Infrastructure Total Return Fund
SRF The Cushing? Energy Income Fund Common
Go

Company profile

Q BioMed, Inc., formerly ISMO Tech Solutions, Inc., is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors. The Company intends to develop these assets to provide returns through organic growth, out-licensing, sale or spin-off into new public companies. The Company holds license for a generic drug, Strontium Chloride (SR89). SR89 is a radiopharmaceutical agent and indicated for the treatment of pain associated with metastatic bone cancer. Its asset, MAN-01, is indicated for the treatment of glaucoma. MAN-01 is in pre-clinical stage. The Company is assessing multiple biomedical assets in various areas of healthcare and drug development. It is pursuing a pipeline of therapeutics, diagnostics and orphan drug candidates.

Closing Price
$1.91
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
76,334
0
  • Prev Close
    1.91
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    76.3K
  • Last (time)
    3:56p ET 03/21/19
  • Last (size)
    200
  • 52-Wk Range
    0.90 - 3.95
    LowHigh
  • (04/05/18 - 12/31/18)
    112.22%
  • 89.2%
  • Market Cap
    27.6M
  • Shares Outstanding
    14.5M
  • -0.68
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 4.3
  • 0.00
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.